We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · May 28, 2022

Association of Oxford–AstraZeneca and Pfizer–BioNTech COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel

Annals of Internal Medicine

 

Additional Info

Annals of Internal Medicine
Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study
Ann. Intern. Med 2022 Apr 01;175(4)541-546, A Hviid, JV Hansen, EM Thiesson, J Wohlfahrt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading